George Clinical welcomes Tony Proctor as Chief Financial Officer

George Clinical, a leading global clinical research company, is pleased to announce the appointment of Tony Proctor, CPA, as Chief Financial Officer (CFO). With more than 25 years of financial leadership experience, Tony brings a wealth of expertise in operational excellence, strategic planning and transformational growth.

“I am honored to join George Clinical and contribute to improving health outcomes through innovative clinical research,” said Tony Proctor. “I look forward to working with the talented team to improve the financial operations and support the company’s global vision.

Tony has served as CFO and in leadership roles at Lexitas, Parexel and Syneos Health. He was a key architect of organic revenue growth initiatives at these companies by implementing world-class financial disciplines, key organizational and systems upgrades, and transformative M&A processes. His leadership skills have consistently delivered measurable results, including driving strategic growth initiatives and optimizing financial operations on a global scale.

“We are delighted to welcome Tony to George Clinical during this exciting phase of our growth,” said Mary Gunn, CEO of George Clinical. “His extensive expertise in financial strategy and operational leadership will be instrumental in advancing our business and delivering exceptional value to our clients around the world.

Tony holds an MBA in Finance from Campbell University, a BS in Accounting, and a BA in Economics/Finance from North Carolina State University. He is also a Certified Public Accountant (CPA) in North Carolina.

About George Clinical George Clinical is a world-leading clinical research company headquartered in Singapore. With scientific excellence and operational expertise, the company provides comprehensive clinical trial services to its customers worldwide, providing solutions for all phases of trials. For more information about George Clinical visit www.georgeclinical.com.